https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

FDA Moves to Restrict 7-OH Opioid Products

FDA Moves to Restrict 7-OH Opioid Products

The FDA targets 7-hydroxymitragynine, a potent kratom derivative, as a controlled substance due to its opioid-like effects and rising health risks.

administrator

Related Articles